A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2006
11/22/2006	EP1723967A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/22/2006	EP1723966A2 Oil in water emulsion vaccines
11/22/2006	EP1723965A1 Compositions for antigen-specific induction of immuno-tolerance via oral immunization
11/22/2006	EP1723963A2 Hapten-conjugated tumour cells
11/22/2006	EP1723178A2 Human g-protein chemokine receptor (ccr5) hdgnr10
11/22/2006	EP1572989B1 Gen 2.2 dendritic cell line
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1401413B1 Use of tyrosine kinase inhibitions for treating allergic diseases
11/22/2006	EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP1054674B1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP1037603B1 Membrane virus host range mutations and their uses as vaccine substrates
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867352A Therapeutic uses of chemokine variants
11/22/2006	CN1867342A A pharmaceutical composition used for treating recurrent spontaneous abortion and method thereof
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1864742A Transfer factor solution applied in livestock and poultry, its preparation method and application thereof
11/22/2006	CN1864695A Clathrate consists of astragaloside and cyclodextrin, its preparation method and application
11/22/2006	CN1864663A Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2 (11),3,5,7,9-pentaene
11/22/2006	CN1285608C Parainfluenza virus glycoproteins and vaccines
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285572C Cannabinod receptor ligands
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
11/21/2006	US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006	US7138429 Flavonoid compound and process for producing the same
11/21/2006	US7138425 Phthalimide carboxylic acid derivatives
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138272 Gene transfer in human lymphocytes using retroviral scFv cell targeting
11/21/2006	US7138244 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
11/21/2006	US7138243 NTB-A, a surface molecule involved in natural killer cells activity
11/21/2006	US7138140 For therapy of allergic diseases, dysuria or pruritus due to kidney dialysis
11/21/2006	US7138125 Polypeptide for prevention, therapy of bacteria infections; gramnegative bacteria; therapy for reduced lactation in animals
11/21/2006	US7138124 Lipopolysaccharides; forming antibodies; isolation exterior membrane polypeptide
11/21/2006	CA2338753C Medicinal aerosol formulations
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/17/2006	CA2549902A1 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
11/16/2006	WO2006121384A1 Method of improving immune function in mammals using 3-hpa producing lactobacillus strains in combination with medium chain triglyceride oil
11/16/2006	WO2006121209A1 Therapeutic agent for eczema and dermatitis
11/16/2006	WO2006120575A2 Tcr-independent activation of t cells with co-lignation of cd28 and cd81
11/16/2006	WO2006119560A1 Immunoglobulin fraction and process therefor
11/16/2006	WO2006031370A3 Polypeptide variants with altered effector function
11/16/2006	WO2005115389A3 Specific ppar agonists for treating negative energy balance
11/16/2006	WO2005115369A3 Use of ppar agonists to treat ruminants
11/16/2006	WO2005103083A3 Anti-cd38 human antibodies and uses therefor
11/16/2006	WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257432 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucelic acid replication
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/16/2006	US20060257401 Sensitizing cells for apoptosis by selectively blocking cytokines
11/16/2006	US20060257364 Materials and methods for inhibition of IgE production
11/16/2006	US20060257330 Powdery pharmaceutical compositions for inhalation
11/16/2006	US20060257329 Delivery of drug esters through an inhalation route
11/16/2006	CA2607281A1 Anti-cd19 antibody therapy for autoimmune disease
11/16/2006	CA2607082A1 Immunoglobulin fraction and process therefor
11/15/2006	EP1721985A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles
11/15/2006	EP1721978A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
11/15/2006	EP1721618A2 Proteosome influenza vaccine composition
11/15/2006	EP1721612A2 Immunemodulating oligosaccharides
11/15/2006	EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720845A1 Isothiourea derivatives
11/15/2006	EP1720835A1 Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors
11/15/2006	EP1720572A1 Monovalent ligand of the fcalphari receptor as an anti-inflammatory agent
11/15/2006	EP1720561A1 Botanical extract composition
11/15/2006	EP1720560A1 Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation of ppr-gamma receptors
11/15/2006	EP1720552A2 Methods for treating inflammatory and autoimmune diseases
11/15/2006	EP1648868B1 Hydroxamate sulfonamides as cd23 shedding inhibitors
11/15/2006	EP1495111A4 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1283869B1 Novel bee venom polypeptides and methods of use thereof
11/15/2006	EP1254659B1 Stable emulsion compositions
11/15/2006	EP1054950B1 Hiv chemokines
11/15/2006	EP1009430B1 Oil in water emulsion vaccines against Hepatitis B

1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 1172